GEFITINIB-DERIVATE

European patent · EP2242493 · Deleted

Register entry

Publication number
EP2242493
Application number
EP09703515
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jan 22, 2009
Published
Oct 27, 2010
Granted
Jun 5, 2013
Deleted
Jan 31, 2014
Reason
Annual fee unpaid
IPC classes
C07D 239/94 (2006.01)
A61P 35/00 (2006.01)
A61K 31/517 (2006.01)
A61K 31/535 (2006.01)
Priority
US 22806 22.01.2008
US 140073 22.12.2008
PCT application
PCT/US2009/000482 22.01.2009
PCT publication
WO2009/094216 30.07.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 20, 2014

    Deleted, fee unpaid

    Published in Swissreg on 20.08.2014

  2. Jun 5, 2013

    Granted

    Published in Swissreg on 05.06.2013

Parties

Holder

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Inc.

99 Hayden Avenue, Suite 500, Lexington, MA 02421, US

Inventor

TUNG, Roger

Lexington, MA 02421, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.